Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2003
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003050095A1 Substituted benzoxazoles and analogues as estrogenic agents
06/19/2003WO2003050090A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003WO2003050067A2 Vitamin d analogues
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003049770A1 Use of an h1 antagonist and a safe steroid to treat rhinitis
06/19/2003WO2003049752A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
06/19/2003WO2003049742A1 Method for administering birb 796 bs
06/19/2003WO2003049741A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049733A1 High-concentration stable meloxicam solutions for needle-less injection
06/19/2003WO2003049726A1 Respiratory infection prevention and treatment with terpene-containing compositions
06/19/2003WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003WO2003049717A2 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049686A2 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003WO2003049680A2 Compositions containing both sedative and non-sedative antihistamines
06/19/2003WO2003049675A2 Treating muscle wasting with selective androgen receptor modulators
06/19/2003WO2003049599A2 Methods and compositions for the diagnosis of asthma
06/19/2003WO2002047674A3 Use of intracellular calcium chelators (e.g bapta-am) to increase surfactant secretion in the lungs
06/19/2003WO2002044342A9 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
06/19/2003WO2002043660A3 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
06/19/2003WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same
06/19/2003US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
06/19/2003US20030114668 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
06/19/2003US20030114537 Medical combinations comprising mometasone and salmeterol
06/19/2003US20030114514 Preventing collagen-based leukocyte adhesion and leukocyte adhesion
06/19/2003US20030114513 Use of isatin derivatives as ion channel activating agents
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114462 Drug abruse, alcoholism; respiratory system disorders, cardiovascular disorders
06/19/2003US20030114456 Antiinflammatory agents, analgesics, antipyretics
06/19/2003US20030114453 Antiinflammatory agents; asthma; skin disorders
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114439 Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/19/2003US20030114428 Pharmaceutical compositions for the treatment of asthma
06/19/2003US20030114418 Analgesics; antiinflammatory and arthritic agents; osteoarthritis; rheumatic diseases; gastrointestinal, nervous system, respiratory disorders; wound healing agents; vision defects; kits
06/19/2003US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/19/2003US20030114384 Methods and compositions for treating lesions of the respiratory epithelium
06/19/2003US20030114375 Method for treating cystic fibrosis
06/19/2003US20030113881 D-enzyme compositions and methods of their use
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113775 7118, a human arginine N-methyltransferase family member and uses therefor
06/19/2003US20030113763 Oligonucleotide compositions and their use to induce apoptosis
06/19/2003US20030113393 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
06/19/2003US20030113377 Orally administered liquid compositions
06/19/2003US20030113366 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/19/2003US20030113269 Medical combinations comprising tiotropium and fluticasone proprionate
06/19/2003CA2469893A1 Phenylalkynes
06/19/2003CA2469889A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/19/2003CA2469607A1 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003CA2469596A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003CA2469588A1 Highly concentrated stable meloxicam solutions for needleless injection
06/19/2003CA2469340A1 Treating muscle wasting with selective androgen receptor modulators
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2468892A1 Vitamin d analogues
06/19/2003CA2468749A1 Use of an h1 antagonist and a safe steroid to treat rhinitis
06/19/2003CA2468659A1 Urea substituted imidazopyridines
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468174A1 Amide substituted imidazopyridines
06/19/2003CA2468164A1 Sulfonamido substituted imidazopyridines
06/19/2003CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
06/19/2003CA2467573A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003CA2465759A1 Method for administering birb 796 bs
06/19/2003CA2464341A1 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
06/18/2003EP1319709A1 Disruption of the glutathione S-transferase-omega-1 gene
06/18/2003EP1319402A1 Ige production inhibitors
06/18/2003EP1319070A2 Mammalian receptor genes and uses
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319008A2 Water soluble rapamycin esters
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318996A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318994A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318993A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318991A1 Benzoic acid derivatives and uses thereof
06/18/2003EP1318983A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318973A2 Novel alkanoic acid derivatives
06/18/2003EP1318828A1 Orally administered peptides to ameliorate atherosclerosis
06/18/2003EP1318827A1 Polymer-modified synthetic proteins
06/18/2003EP1318816A1 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318811A1 Cyclopentyl modulators of chemokine receptor activity
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/18/2003EP1011709A4 Inhibition of apoptotis using prosaposin receptor agonists
06/18/2003EP0821739B1 An adenovirus helper-virus system
06/18/2003EP0819125B1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/18/2003CN1425016A Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments
06/18/2003CN1425012A Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2
06/18/2003CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/18/2003CN1425005A Cyclic quaternary ammonium compound
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1424909A Formulations for use in inhaler devices
06/18/2003CN1424084A Honeysuckle flower and coptis root powder injection and its preparing method
06/18/2003CN1424082A Asthma relieving paste for child
06/18/2003CN1424078A Medicine for acute pulmonary infection and its preparing method
06/18/2003CN1424068A Medicines for treating acute and chronic pharyngitis
06/18/2003CN1424065A Medicine for nasal obstruction
06/18/2003CN1424053A Capsule agent of chanhua mycelia and preparing method thereof
06/18/2003CN1424029A Medicines for preventing pneumoconiosis
1 ... 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 ... 878